Nikola recently transferred to Northeastern University and is a third-year undergraduate in the Linguistics program. Her interests lay within early-childhood developmental education, but she is eager to join the TAN Lab to further develop her understanding in adult communication and motor disorders. Nikola has worked in Speech & Language Pathology offices, focussing on students with apraxia of speech and other communication disorders. However, in her time working with both students and their families, she has noticed the support systems upholding the students do not always receive parallel aid. Nikola hopes to work in the private sector of education and eventually plans to open her own business that focuses on educational programs for both children and their families to smoothly transition into therapy treatment. Out of the lab, Nikola enjoys reading, working with her nieces and nephews in their own developmental stages, and spending time with friends. 

Margaret is a second-year graduate student in the Master of Science in Speech-Language Pathology program at Northeastern. She received her Bachelor of Science in Communication Sciences and Disorders at Southern Connecticut State University where she developed an interest in neurodegenerative diseases and cognitive rehabilitation following cerebrovascular accidents and traumatic brain injuries. Outside of the lab, Margaret serves on the Executive Board for the Northeastern University Student Speech-Language and Hearing Association (NUSSLHA).

Julia is a 2nd-year graduate student at Northeastern University studying Speech-Language Pathology. She is also a student in the TAN-Lab run by Dr. Erin Meier. Her research interests include neuroimaging related to receptive and expressive language. She received her B.S. in Communication Disorders from The University of Rhode Island in 2020. Julia values client-centered therapeutic approaches and hopes that her educational and research experiences will guide her in providing individualized and effective treatment across the lifespan in her future practice.